CD8A and melanoma: However, at least in the case of melanoma, EVs-mediated transfer of tumor antigens to LN LECs and subsequent presentation on MHC-I rather inhibited the response of CD8+ T cells, most likely due to the inherent tolerogenic capacity of LN LECs [65].